Stocktoria
Edwards Lifesciences Corp EW
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2000-03-27
Edwards Lifesciences Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 78.0% | 79.5% | 80.5% | 83.8% | 76.1% |
| Operating margin | 20.8% | 25.3% | 26.1% | 33.6% | 32.3% |
| Net margin | 17.7% | 76.7% | 28.0% | 34.1% | 28.7% |
| FCF margin | 22.0% | 5.3% | 12.8% | 21.8% | 26.9% |
| Return on assets | 7.8% | 32.0% | 15.0% | 18.4% | 17.7% |
| Return on equity | 10.4% | 41.5% | 20.9% | 26.2% | 25.8% |
| Debt / equity | 0.06× | 0.06× | 0.09× | 0.10× | 0.10× |
| Current ratio | 3.72 | 4.18 | 3.38 | 3.03 | 3.08 |
| Revenue growth | 11.5% | 8.6% | 12.2% | -14.7% | 19.3% |
Source: SEC EDGAR filings · CIK 0001099800 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.